Daratumumab Monoclonal Antibody from China
Daratumumab is a human IgG1k monoclonal antibody targeting CD38, used for the treatment of multiple myeloma. As an unmixed bulk product not in measured doses or retail packaging, it is classifiable under tariff item 3002.13.00.
Duty Rate — China → Canada
0%
Import Tips
• Verify the product is not dissolved in any solvent or mixed with stabilizers to retain the unmixed classification
• Provide a certificate of analysis to CBSA confirming the product's purity and biotechnological origin
• Confirm whether a Canadian establishment licence is required for the importing facility